Annual ROE
-55.51%
-12.75%-29.82%
31 December 2023
Summary:
Allogene Therapeutics annual return on equity is currently -55.51%, with the most recent change of -12.75% (-29.82%) on 31 December 2023. During the last 3 years, it has fallen by -26.21% (-89.45%). ALLO annual ROE is now -205.67% below its all-time high of -18.16%, reached on 31 December 2021.ALLO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-58.07%
-4.12%-7.64%
30 September 2024
Summary:
Allogene Therapeutics quarterly return on equity is currently -58.07%, with the most recent change of -4.12% (-7.64%) on 30 September 2024. Over the past year, it has dropped by -4.39% (-8.18%). ALLO quarterly ROE is now -223.33% below its all-time high of -17.96%, reached on 31 December 2021.ALLO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALLO ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.8% | -8.2% |
| 3 y3 years | -89.5% | -89.8% |
| 5 y5 years | -84.5% | -150.6% |
ALLO ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -205.7% | at low | -223.3% | at low |
| 5 y | 5 years | -205.7% | at low | -223.3% | at low |
| alltime | all time | -205.7% | at low | -223.3% | +81.8% |
Allogene Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -58.07%(+7.6%) |
| June 2024 | - | -53.95%(+2.3%) |
| Mar 2024 | - | -52.73%(-4.1%) |
| Dec 2023 | -55.51%(+29.8%) | -54.96%(+2.4%) |
| Sept 2023 | - | -53.68%(+0.7%) |
| June 2023 | - | -53.30%(+8.1%) |
| Mar 2023 | - | -49.30%(+15.5%) |
| Dec 2022 | -42.76%(+135.5%) | -42.67%(+54.1%) |
| Sept 2022 | - | -27.69%(+8.9%) |
| June 2022 | - | -25.43%(+7.6%) |
| Mar 2022 | - | -23.63%(+31.6%) |
| Dec 2021 | -18.16% | -17.96%(-41.3%) |
| Sept 2021 | - | -30.59%(+7.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | -28.41%(+6.7%) |
| Mar 2021 | - | -26.62%(-16.5%) |
| Dec 2020 | -29.30%(-0.2%) | -31.89%(+15.5%) |
| Sept 2020 | - | -27.60%(-8.3%) |
| June 2020 | - | -30.11%(-8.9%) |
| Mar 2020 | - | -33.05%(+15.7%) |
| Dec 2019 | -29.35%(-2.4%) | -28.56%(+23.3%) |
| Sept 2019 | - | -23.17%(-26.2%) |
| June 2019 | - | -31.38%(-51.2%) |
| Mar 2019 | - | -64.24%(-17.4%) |
| Dec 2018 | -30.08% | -77.73%(-75.7%) |
| Sept 2018 | - | -319.87%(+555.1%) |
| June 2018 | - | -48.83% |
FAQ
- What is Allogene Therapeutics annual return on equity?
- What is the all time high annual ROE for Allogene Therapeutics?
- What is Allogene Therapeutics annual ROE year-on-year change?
- What is Allogene Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Allogene Therapeutics?
- What is Allogene Therapeutics quarterly ROE year-on-year change?
What is Allogene Therapeutics annual return on equity?
The current annual ROE of ALLO is -55.51%
What is the all time high annual ROE for Allogene Therapeutics?
Allogene Therapeutics all-time high annual return on equity is -18.16%
What is Allogene Therapeutics annual ROE year-on-year change?
Over the past year, ALLO annual return on equity has changed by -12.75% (-29.82%)
What is Allogene Therapeutics quarterly return on equity?
The current quarterly ROE of ALLO is -58.07%
What is the all time high quarterly ROE for Allogene Therapeutics?
Allogene Therapeutics all-time high quarterly return on equity is -17.96%
What is Allogene Therapeutics quarterly ROE year-on-year change?
Over the past year, ALLO quarterly return on equity has changed by -4.39% (-8.18%)